This was the last monoclonal antibody drug authorized by the FDA to treat COVID-19. The decision was made because it is not expected to neutralize new Omicron subvariants.

Evusheld is a monoclonal antibody therapy used to prevent Covid-19 infection. Jonathan Nackstrand/AFP via Getty Images Monoclonal antibodies were also used to prevent Covid-19 in high-risk patients.

A monoclonal antibody treatment made by GlaxoSmithKline and Vir is no longer authorized to treat COVID-19 in the US because it doesn't work against omicron's subvariant, BA.2, the US Food and Drug ...

Experts stress that while antibody therapy is an option, vaccination remains the most powerful way to combat COVID-19 infection. Here’s what we know so far about monoclonal antibody therapy, how ...

Monoclonal antibody treatments have given new hope for those fighting COVID-19, and they've been intensely politicized as well. Millions in the South, for example, rejected vaccination in favor of ...

Monoclonal antibody treatments, which are delivered intravenously or by injection, mimic the immune system’s ability to fight off harmful antigens such as viruses, according to the U.S. Food ...

In general, patients should get a doctor’s referral before receiving treatment — they can’t just walk into most infusion centers. A physician can determine if the monoclonal antibody therapy ...

The single remaining monoclonal antibody therapy effective against the variant is now in short supply in the U.S., imperiling an option that doctors and hospitals have relied on.

The two monoclonal antibody products that have been authorized for emergency use by the FDA, from the drugmakers Eli Lilly and Regeneron, must be given within the first week of illness.

Monoclonal antibodies mimic the body’s ability to fight off viruses, and have been vital in the fight against Covid. Here’s what it is and where you can get it.